3,208 Shares in U.S. Physical Therapy, Inc. $USPH Acquired by CWC Advisors LLC.

Key Points

• CWC Advisors LLC has made a new investment in U.S. Physical Therapy, purchasing 3,208 shares valued at approximately $251,000 during the second quarter.
• The company recently declared a quarterly dividend of $0.45 per share, providing an annualized yield of 2.2% and a payout ratio of 78.6%.
• U.S. Physical Therapy reported an earnings per share (EPS) of $0.81 for the last quarter, exceeding analysts' expectations of $0.71, with a revenue growth of 18.0% year-over-year.

CWC Advisors LLC. purchased a new position in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 3,208 shares of the company's stock, valued at approximately $251,000.

Other hedge funds also recently added to or reduced their stakes in the company. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in U.S. Physical Therapy by 952.4% during the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 442 shares of the company's stock valued at $32,000 after purchasing an additional 400 shares during the last quarter. Parallel Advisors LLC boosted its stake in shares of U.S. Physical Therapy by 90.6% during the second quarter. Parallel Advisors LLC now owns 448 shares of the company's stock valued at $35,000 after purchasing an additional 213 shares in the last quarter. Lazard Asset Management LLC bought a new position in shares of U.S. Physical Therapy during the fourth quarter valued at approximately $84,000. Fifth Third Bancorp boosted its stake in shares of U.S. Physical Therapy by 34.6% during the first quarter. Fifth Third Bancorp now owns 1,030 shares of the company's stock valued at $75,000 after purchasing an additional 265 shares in the last quarter. Finally, AlphaQuest LLC bought a new position in shares of U.S. Physical Therapy during the first quarter valued at approximately $92,000.

Insider Activity at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,792 shares of the company's stock in a transaction on Monday, August 11th. The shares were sold at an average price of $86.57, for a total transaction of $155,133.44. Following the completion of the transaction, the chief operating officer owned 22,246 shares in the company, valued at approximately $1,925,836.22. This represents a 7.45% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Christopher J. Reading sold 2,000 shares of the stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $83.53, for a total transaction of $167,060.00. Following the completion of the sale, the chief executive officer directly owned 114,088 shares in the company, valued at approximately $9,529,770.64. The trade was a 1.72% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 6,853 shares of company stock worth $581,406 in the last 90 days. Corporate insiders own 2.00% of the company's stock.

Wall Street Analyst Weigh In

USPH has been the subject of a number of analyst reports. Wall Street Zen cut shares of U.S. Physical Therapy from a "buy" rating to a "hold" rating in a research report on Sunday. Zacks Research raised shares of U.S. Physical Therapy to a "hold" rating in a research report on Friday, August 8th. JPMorgan Chase & Co. assumed coverage on shares of U.S. Physical Therapy in a report on Thursday, September 18th. They issued an "overweight" rating and a $110.00 price target for the company. Finally, Barrington Research raised their price target on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

U.S. Physical Therapy Trading Down 0.1%

NYSE:USPH traded down $0.05 on Tuesday, hitting $79.83. The stock had a trading volume of 13,976 shares, compared to its average volume of 141,717. The company has a fifty day moving average price of $80.33 and a two-hundred day moving average price of $76.39. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of 34.82, a PEG ratio of 3.93 and a beta of 1.47. U.S. Physical Therapy, Inc. has a 1-year low of $62.77 and a 1-year high of $101.19. The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 0.30.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a net margin of 5.05% and a return on equity of 8.78%. The firm had revenue of $197.34 million for the quarter, compared to the consensus estimate of $190.24 million. During the same period in the prior year, the firm earned $0.73 EPS. The firm's revenue for the quarter was up 18.0% on a year-over-year basis. Equities research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 12th. Investors of record on Friday, August 22nd were paid a dividend of $0.45 per share. The ex-dividend date was Friday, August 22nd. This represents a $1.80 dividend on an annualized basis and a yield of 2.3%. U.S. Physical Therapy's dividend payout ratio is currently 78.60%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.